Submission Details
| 510(k) Number | K964764 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 1996 |
| Decision Date | January 24, 1997 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K964764 is an FDA 510(k) clearance for the OPUS BONE ALP, a Electrophoretic Separation, Alkaline Phosphatase Isoenzymes (Class II — Special Controls, product code CIN), submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on January 24, 1997, 58 days after receiving the submission on November 27, 1996. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1050.
| 510(k) Number | K964764 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 1996 |
| Decision Date | January 24, 1997 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CIN — Electrophoretic Separation, Alkaline Phosphatase Isoenzymes |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1050 |